Tristel plc (AIM:TSTL)

Market Cap	174.11M
Revenue (ttm)	43.56M
Net Income (ttm)	6.14M
Shares Out	47.70M
EPS (ttm)	0.13
PE Ratio	28.34
Forward PE	21.55
Dividend	0.14 (3.70%)
Ex-Dividend Date	Mar 20, 2025

Volume	75,886
Average Volume	109,808
Open	368.89
Previous Close	365.00
Day's Range	365.00 - 377.00
52-Week Range	260.00 - 510.00
Beta	0.17
RSI	69.47
Earnings Date	May 23, 2025

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments, Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 233
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TSTL

Financial Performance

In 2024, Tristel's revenue was 41.93 million, an increase of 16.45% compared to the previous year's 36.01 million. Earnings were 6.49 million, an increase of 45.46%.